Eledon shareholders approve 3.5M share increase to 2020 incentive plan; director Ogier retires, committees reshuffled

Eledon Pharmaceuticals, Inc.

Stockholders approved amendment to 2020 Long Term Incentive Plan, increasing share reserve by 3.5M to 17.96M shares and extending grant period to May 2034.
Class I directors Steven Perrin and June Lee elected to three-year terms with 18.4M and 17.3M votes for, respectively.
Walter Ogier retired from board effective July 10; Audit, Compensation, and Nominating committees restructured with new members.
KMJ Corbin & Company LLP ratified as independent auditor for fiscal 2024 with 23.1M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.